Methods, compositions, and systems for capturing probes and/or barcodes
Provided herein are methods for capturing a connected probe and/or a capture handle sequence to a capture domain of a capture probe.
1. A method for processing a nucleic acid analyte in a biological sample mounted on a first substrate, the method comprising:
(a) hybridizing a first probe and a second probe to the nucleic acid analyte, wherein the first probe and the second probe each comprise a sequence that is substantially complementary to sequences of the nucleic acid analyte, and wherein the second probe comprises a capture probe binding domain;
(b) coupling the first probe and the second probe, thereby generating a connected probe;
(c) aligning the first substrate with a second substrate comprising an array, such that at least a portion of the biological sample is aligned with at least a portion of the array, wherein the array comprises a plurality of capture probes, wherein a capture probe of the plurality of capture probes comprises: (i) a spatial barcode and (ii) a capture domain;
(d) releasing the connected probe from the nucleic acid analyte when at least a portion of the biological sample is aligned with at least a portion of the array; and
(e) hybridizing the connected probe to the capture domain of the capture probe on the array.
2. The method of claim 1 , wherein the first probe and the second probe hybridize to adjacent sequences.
3. The method of claim 1 , wherein the first probe and the second probe hybridize to sequences that are at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more nucleotides away from one another.
4. The method of claim 3 , further comprising (i) generating an extended first probe, wherein the extended first probe comprises a sequence complementary to a sequence between the sequence hybridized to the first probe and the sequence hybridized to the second probe; or (ii) an extended second probe using a polymerase, wherein the extended second probe comprises a sequence complementary to a sequence between the sequence hybridized to the first probe and the sequence hybridized to the second probe.
5. The method of claim 1 , wherein the coupling the first probe and the second probe comprises ligating the first probe and the second probe.
6. The method of claim 4 , wherein the coupling the first probe and the second probe comprises ligating:
the first probe and the extended second probe; or
the extended first probe and the second probe.
7. The method of claim 5 , wherein the ligating is performed via a ligase.
8. The method of claim 7 , wherein the ligase is selected from a Chlorella virus DNA ligase, a single-stranded DNA ligase, or a T4 DNA ligase.
9. The method of claim 1 , wherein the aligning comprises:
mounting the first substrate on a first member of a support device, the first member configured to retain the first substrate;
mounting the second substrate on a second member of the support device;
applying a reagent medium to the first substrate and/or the second substrate; and
operating an alignment mechanism of the support device to move the first member and/or the second member such that at least a portion of the biological sample is aligned with at least a portion of the array, and such that the portion of the biological sample and the portion of the array contact the reagent medium.
10. The method of claim 9 , wherein the alignment mechanism is coupled to the first member, the second member, or both the first member and the second member.
11. The method of claim 9 , wherein the alignment mechanism comprises a linear actuator, optionally wherein:
the linear actuator is configured to move the second member along an axis orthogonal to the plane or the first member and/or the second member, and/or
the linear actuator is configured to move the first member along an axis orthogonal to the plane of the first member and/or the second member, and/or
the linear actuator is configured to move the first member, the second member, or both the first member and the second member at a velocity of at least 0.1 mm/sec, and/or
the linear actuator is configured to move the first member, the second member, or both the first member and the second member with an amount of force of at least 0.1 lbs.
12. The method of claim 9 , wherein at least one of the first substrate and the second substrate further comprise a spacer disposed on the first substrate or the second substrate, wherein when at least the portion of the biological sample is aligned with at least a portion of the array such that the portion of the biological sample and the portion of the array contact the reagent medium, the spacer is disposed between the first substrate and the second substrate and is configured to maintain the reagent medium within a chamber formed by the first substrate, the second substrate, and the spacer, and to maintain a separation distance between the first substrate and the second substrate, wherein the spacer is positioned to surround an area on the first substrate on which the biological sample is disposed and/or the array disposed on the second substrate, wherein the area of the first substrate, the spacer, and the second substrate at least partially encloses a volume comprising the biological sample.
13. The method of claim 1 , wherein the releasing step (d) comprises contacting the biological sample with a reagent medium comprising a permeabilization agent and an agent for releasing the connected probe, thereby permeabilizing the biological sample and releasing the connected probe from the nucleic acid analyte.
14. The method of claim 13 , wherein the agent for releasing the connected probe comprises a nuclease.
15. The method of claim 14 , wherein the nuclease comprises an RNase, optionally wherein the RNase is selected from RNase A, RNase C, RNase H, or RNase I.
16. The method of claim 13 , wherein the permeabilization agent comprises a protease.
17. The method of claim 16 , wherein the protease is selected from trypsin, pepsin, elastase, or proteinase K.
18. The method of claim 1 , further comprising determining (i) all or a part of the sequence of the connected probe, or a complement thereof, and (ii) the spatial barcode, or a complement thereof, and using the determined sequence of (i) and (ii) to determine a location of the nucleic acid analyte in the biological sample.
19. The method of claim 18 , wherein the determining comprises sequencing (i) all or a part of the sequence of the connected probe, or a complement thereof, and (ii) the sequence of the spatial barcode, or a complement thereof.
20. The method of claim 1 , wherein the capture probe comprises a poly(T) sequence, one or more functional domains, a unique molecular identifier (UMI), a cleavage domain, or combinations thereof.
21. The method of claim 1 , wherein the nucleic acid analyte is RNA.
22. The method of claim 21 , wherein the RNA is mRNA.
23. The method of claim 1 , further comprising processing a different type of analyte in the biological sample.
24. The method of claim 23 , wherein the processing the different type of analyte comprises:
before (c), contacting the biological sample with a plurality of analyte capture agents, wherein an analyte capture agent of the plurality of analyte capture agents comprises an analyte binding moiety and a capture agent barcode domain, wherein the analyte binding moiety specifically binds to the different type of analyte, and wherein the capture agent barcode domain comprises an analyte binding moiety barcode and a capture handle sequence; and
hybridizing the capture handle sequence to the capture domain of the capture probe on the array.
25. The method of claim 24 , further comprising determining (i) all or part of the sequence of the capture agent barcode domain; and (ii) the spatial barcode, or a complement thereof, and using the determined sequence of (i) and (ii) to analyze the different type of analyte in the biological sample.
26. The method of claim 24 , further comprising a releasing step, wherein the capture agent barcode domain is released from the different type of analyte.
27. The method of claim 24 , wherein the different type of analyte is a protein analyte.
28. The method of claim 1 , wherein the biological sample is a tissue sample.
29. The method of claim 1 , wherein the biological sample is a formalin fixed paraffin embedded (FFPE) tissue sample.
30. The method of claim 29 , wherein the tissue sample is fixed and stained prior to step (a).